Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (1449)	1/30/2002 5:16:26 PM
From: Icebrg	Read Replies (1) \| Respond to of 10345

Arnie I think all these "half-secret" cooperation agreements are one of the most interesting aspects of Elan. Even though it is difficult to get a grip on them. I also believe that most of them are attractive and in the shareholder's interest. What it all seems to boil down to in most cases is that Elan gives the partner the right to use some aspect of Elan's technology against a share in the partner's and/or the J-V's equity. Sometimes they also get the marketing rights to any drug coming out of the cooperation. Nothing wrong with that. On the contrary. Most of these company were most probably not able or willing to buy the technology outright, anyhow. Some of the arrangements are however difficult to understand. Like the one they did with Xcel. How could Xcel pay so much for what appears to be relatively minor drugs? It will be interesting to see if Xcel manages to float their IPO. I guess the market sentiment is not the very best at the moment. I bought some more today at just over 25. A chance like this might never come back. Or it will - before the end of this week. Om Monday we will probably know. Ice